Search
Now showing items 1-2 of 2
Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?
(Lippincott, Williams & Wilkins, 2015)
One of the most important adverse effects of zoledronic acid (ZA) is osteonecrosis of the jaw (ONJ). In previous literature, several risk factors have been identified in the development of ONJ. In this study, we aimed to ...
Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients
(SPANDIDOS PUBL LTD, 2015)
The aim of the present study was to identify the optimal Ki-67 cut-off value in breast cancer (BC) patients, and investigate the association of Ki-67 expression levels with other prognostic factors. Firstly, a retrospective ...